Refractory Congenital Chylous Ascites

Melo-Filho, Antônio Aldo; Souza, Ivana Jesus Nogueira; Leite, Christiane Araujo Chaves; Leite, Raquel Crosara Maia; Colares, João Henrique Freitas; Correia, Júlio Marcus Sousa

doi:10.1007/s12098-010-0193-z

Cited by 13 publications

(27 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As for causes of chylous ascites, congenital chylous ascites, idiopathic chylous ascites, chylous ascites after laparotomy, protein‐losing enteropathy, LM, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia were reported. None of the papers evaluated treatments according to the cause.…”

Section: <Summary>mentioning

confidence: 99%

“…MCT was used before, after, and during treatment . In the multicenter case series by Bellini et al ., MCT was reportedly performed in 14 patients without adverse effects.…”

Section: <Summary>mentioning

confidence: 99%

“…According to the single‐center case series by Zeidan et al ., surgical treatment was performed in patients who responded poorly to conservative treatments for over a mean of 25.3 days. In other reports, surgical treatment was performed after conservative treatments for 1–3 months and in patients with congenital chylous ascites 1–4 months after birth . Since it is often impossible to identify the leakage site of chylous ascites, attempts to identify the leakage site by orally administering a lipophilic dye (Sudan black, Sudan III) before operation .…”

Section: <Summary>mentioning

confidence: 99%

“…Since it is often impossible to identify the leakage site of chylous ascites, attempts to identify the leakage site by orally administering a lipophilic dye (Sudan black, Sudan III) before operation . When the leakage site can be identified, ligation, suturing, clipping, and cauterization have been performed . In addition to reports of the usefulness of techniques to stop leakage, such as applying or sprinkling fibrin glue at the leakage site of chylous ascites or over the surrounding retroperitoneum and applying a patch of oxidized cellulose/resorbable local hemostatic agent, there have also been reports of peritoneovenous shunting and peritoneoamniotic shunting for fetal cases…”

Section: <Summary>mentioning

confidence: 99%

See 3 more Smart Citations

Japanese clinical practice guidelines for vascular anomalies 2017

Mimura

Akita

Fujino

et al. 2020

Pediatrics International

View full text Add to dashboard Cite

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence‐based guidelines for the management of vascular anomalies.

show abstract

Section: <Summary>mentioning

confidence: 99%

“…MCT was used before, after, and during treatment . In the multicenter case series by Bellini et al ., MCT was reportedly performed in 14 patients without adverse effects.…”

Section: <Summary>mentioning

confidence: 99%

Section: <Summary>mentioning

confidence: 99%

Section: <Summary>mentioning

confidence: 99%

See 2 more Smart Citations

Japanese clinical practice guidelines for vascular anomalies 2017

Mimura

Akita

Fujino

et al. 2020

Pediatrics International

View full text Add to dashboard Cite

show abstract

“…Of these, in two cases the treatment with octreotide failed resulting in surgical intervention 8 9. Therefore, only five cases of CCA including our case were successfully treated with octreotide.…”

Section: Discussionmentioning

confidence: 90%

Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn

et al. 2012

View full text Add to dashboard Cite

Congenital chylous ascites (CCA) is a rare disease that results from maldevelopment of the intra-abdominal lymphatic system. Few cases have been described and no gold standard treatment has been defined so far. Octreotide, a somatostatin analogue, has been used for the treatment of CCA, but always after a failed conservative approach with fasting, total parenteral nutrition (TPN) or medium chain triglyceride (MCT) feeds. We report the case of a newborn with CCA treated by fasting, TPN and octreotide for a period of 15 days until the abdominal distension was successfully reduced at which point treatment was switched to an MCT formula. On day 25 the patient was breastfed and was discharged on day 33. No recurrence of chylous ascites was noted. Our experience highlights the successful treatment with TPN and octreotide as the first step for the conservative approach of CCA in a newborn, reducing the length of treatment and hospitalisation.

show abstract

Japanese clinical practice guidelines for vascular anomalies 2017

et al. 2020

View full text Add to dashboard Cite

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

show abstract

Refractory Congenital Chylous Ascites

Cited by 13 publications

References 6 publications

Japanese clinical practice guidelines for vascular anomalies 2017

Japanese clinical practice guidelines for vascular anomalies 2017

Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn

Japanese clinical practice guidelines for vascular anomalies 2017

Contact Info

Product

Resources

About